HomePage

About Us

Istituto Gentili is an Italian biopharmaceutical company with over a century of history and expertise in the development and commercialization of innovative molecules - both of its own and made in partnership.

Our History

In the last years Istituto Gentili has undergone a virtuous growth of its business, allowing the company to equip itself with an articulated product portfolio.

XXXX

In 2009, the Mediolanum Group acquired Istituto Gentili (the Italian subsidiary of Merck focused on orthopedics and respiratory) and Neopharmed (the Italian subsidiary of Merck focused on cardiology).

XXXX

In 2017, Istituto Gentili was established as a specialized entity in oncology, also including the areas of hematology and supportive care for cancer patients.

XXXX

This was achieved through the progressive acquisition of products in the Italian market, including molecules such as fentanyl, aromatase inhibitors, miconazole, and others, leading to a portfolio of around 14 highly specialized brands in oncology care, providing 360° support to oncology patients.

XXXX

Today, Istituto Gentili is expanding its boundaries and entering Europe with two new products based on Fentanyl for the treatment of Breakthrough Cancer Pain and Chronic Pain that will be available in 20 countries all over Europe.

Our Mission

Istituto Gentili's mission is to accompany patients throughout the treatment path, offering innovative personalized treatments and supportive therapies, in order to increase survival and improve quality of life.

Istituto Gentili wants to present and consolidate itself as a reliable partner of the healthcare professionals to:

  • Build care pathways aimed at preventing and treating cancer and allowing patients and family members to make the best decisions for their health;
  • Offer high quality therapeutic solutions, capable of supporting an optimal all-round management of patients suffering from severe neoplasms.

Our pillars are:

Innovation, transparency, centrality of the patient's need, constant cooperation with the scientific community.

Continuous search for solutions and tools to improve people's health and well-being.

Attention to internal human resources, with the creation of a fertile and motivating work environment that fosters full personal and professional fullfilment.

The company has
four strategic lines:

  • High level management skills
  • Focus on oncology, oncohematology, pain, and supportive therapies
  • Partnerships with the main leaders in the reference markets
  • Cooperation with the scientific community
Where We Are

Istituto Gentili keeps consolidating its presence in several countries.

Owned offices
Network offices
Loading data...